Published in J Fr Ophtalmol on February 01, 2003
A multicentre report from the Mexican Retinoblastoma Group. Br J Ophthalmol (2004) 1.05
Systemic carboplatin for retinoblastoma: change in tumour size over time. Br J Ophthalmol (2005) 0.81
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med (1999) 6.88
Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. The Breast Carcinoma Collaborative Group of the Institut Curie. Lancet (1992) 5.49
Age as prognostic factor in premenopausal breast carcinoma. Lancet (1993) 4.31
Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer (1996) 2.95
Serious infections from Bacillus sp. JAMA (1979) 2.67
Prevention of venous thromboembolism after knee arthroplasty. A randomized, double-blind trial comparing enoxaparin with warfarin. Ann Intern Med (1996) 2.22
Association of p53 mutations with short survival in colorectal cancer. Gastroenterology (1994) 2.19
Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. Neurology (2001) 2.18
Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation (2004) 2.05
Survival and acquired genetic alterations in colorectal cancer. Gastroenterology (1992) 2.02
Endocarditis caused by Rochalimaea henselae. Hum Pathol (1993) 1.99
Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers. Br J Cancer (1996) 1.97
Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci (2000) 1.85
Delayed diagnosis of pulmonary tuberculosis in city hospitals. Arch Intern Med (1994) 1.76
Bacillus cereus panophthalmitis: source of the organism. Rev Infect Dis (1982) 1.74
Familial invasive breast cancers: worse outcome related to BRCA1 mutations. J Clin Oncol (2000) 1.71
Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study. J Clin Oncol (2005) 1.70
Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost (2008) 1.67
Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study. J Clin Oncol (2002) 1.63
Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6. Eur J Cancer (1994) 1.60
Multi-state Markov models in cancer screening evaluation: a brief review and case study. Stat Methods Med Res (2010) 1.60
Toxoplasma encephalitis in patients with acquired immune deficiency syndrome: diagnosis and response to therapy. Am J Trop Med Hyg (1987) 1.56
Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution. Cancer (1996) 1.55
[Impact of CRP rapid test in management of febrile children in paediatric emergency units of Ile-de-France]. Arch Pediatr (2006) 1.53
Prognostic value of tumor regression during radiotherapy for head and neck cancer: a prospective study. Int J Radiat Oncol Biol Phys (1995) 1.52
Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSF. Hum Mutat (2004) 1.52
External radiotherapy for carcinoma of the eyelid: report of 850 cases treated. Int J Radiat Oncol Biol Phys (1996) 1.50
Five vs. ten days of antibiotic therapy for acute otitis media in young children. Pediatr Infect Dis J (2000) 1.49
Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol (2001) 1.48
Successful treatment of a saphenous vein graft perforation with an autologous vein-covered stent. Catheter Cardiovasc Interv (1999) 1.47
Portal vein thrombosis during antineoplastic chemotherapy in children: report of five cases and review of the literature. Eur J Cancer (2004) 1.47
Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial. Neurology (2006) 1.47
Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks. Int J Radiat Oncol Biol Phys (1996) 1.46
Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children. Clin Infect Dis (2014) 1.44
Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non hereditary retinoblastoma. Hum Mol Genet (1995) 1.44
Patterns of MRI lesions in CADASIL. Neurology (1998) 1.43
Protracted continuous infusion of 5-fluorouracil in combination with doxorubicin, vincristine, and oral cyclophosphamide in advanced breast cancer. Cancer Invest (1996) 1.42
European collaboration in trials of new agents for children with cancer. Eur J Cancer (2004) 1.42
The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma. Mol Pathol (2000) 1.41
A multivariate primary tumour control analysis in 465 patients treated by radical radiotherapy for cancer of the tonsillar region: clinical and treatment parameters as prognostic factors. Radiother Oncol (1989) 1.40
A new 123I-MIBG whole body scan scoring method--application to the prediction of the response of metastases to induction chemotherapy in stage IV neuroblastoma. Eur J Cancer (1995) 1.38
Breast cancer in elderly women: a retrospective analysis of combined treatment with tamoxifen and once-weekly irradiation. Int J Radiat Oncol Biol Phys (1995) 1.38
Modelling the effect of breast cancer screening on related mortality using French data. Cancer Epidemiol (2010) 1.37
Contralateral breast cancer: annual incidence and risk parameters. J Clin Oncol (1995) 1.32
Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: major importance of the mitotic count as a component of both grading systems. Anticancer Res (1998) 1.32
Dark matter results from 225 live days of XENON100 data. Phys Rev Lett (2012) 1.31
Impact of targeting deviations on outcome in medulloblastoma: study of the French Society of Pediatric Oncology (SFOP). Int J Radiat Oncol Biol Phys (1999) 1.30
Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Branhamella catarrhalis in children with respiratory tract infections. Clin Infect Dis (2000) 1.27
A regression survival model for testing the proportional hazards hypothesis. Biometrics (1996) 1.27
Hereditary cerebral cavernous angiomas: clinical and genetic features in 57 French families. Société Française de Neurochirurgie. Lancet (1998) 1.25
Detection of chromosome imbalances in retinoblastoma by parallel karyotype and CGH analyses. Genes Chromosomes Cancer (2000) 1.21
Outbreak of Clostridium difficile-related diarrhoea in an adult oncology unit: risk factors and microbiological characteristics. J Hosp Infect (2003) 1.19
Effect of adjuvant chemotherapy on outcome in patients with metastatic breast carcinoma treated with first-line doxorubicin-containing chemotherapy. Cancer (2001) 1.17
Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysis. Cancer (1988) 1.17
Dark matter results from 100 live days of XENON100 data. Phys Rev Lett (2011) 1.16
Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen. Cancer (1996) 1.16
Combined proton beam radiotherapy and transpupillary thermotherapy for large uveal melanomas: a randomized study of 151 patients. Ophthalmic Res (2006) 1.15
Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation. Eur J Clin Microbiol Infect Dis (2007) 1.15
[Management of malignant phyllodes tumors of the breast: the experience of the Institut Curie]. Cancer Radiother (2009) 1.15
Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. J Thromb Haemost (2004) 1.14
Parental consent in paediatric clinical research. Arch Dis Child (2005) 1.14
Validation of the EORTC QLQ-SAT32 cancer inpatient satisfaction questionnaire by self- versus interview-assessment comparison. Patient Educ Couns (2004) 1.14
Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France. Vaccine (2009) 1.14
Late and ultra late onset Streptococcus B meningitis: clinical and bacteriological data over 6 years in France. Acta Paediatr (2010) 1.13
Paediatric varicella hospitalisations in France: a nationwide survey. Clin Microbiol Infect (2007) 1.13
Second malignancies after breast cancer: the impact of different treatment modalities. Br J Cancer (2008) 1.13
Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer. Br J Cancer (2000) 1.12
Mycobacterium chelonei infection of porcine heart valves. N Engl J Med (1977) 1.12
Hepatic resection in metastatic breast cancer: results and prognostic factors. Eur J Surg Oncol (2000) 1.12
Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: preliminary results. Br J Ophthalmol (1998) 1.11
Surgical management of liver metastases from uveal melanoma: 16 years' experience at the Institut Curie. Eur J Surg Oncol (2009) 1.11
Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab. Br J Cancer (2013) 1.11
An infant with Down syndrome and retinoblastoma. A possible non-fortuitous association. Ophthalmic Genet (2001) 1.08
Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes. Genes Immun (2012) 1.08
Prognostic factors in inflammatory breast cancer and therapeutic implications. Eur J Cancer (1994) 1.08
Effect of clinical spectrum, inoculum size and physician characteristics on sensitivity of a rapid antigen detection test for group A streptococcal pharyngitis. Eur J Clin Microbiol Infect Dis (2013) 1.07
Survival in early-onset BRCA1 breast-cancer patients. Institut Curie Breast Cancer Group. Lancet (1998) 1.07
Breast tumour response to primary chemotherapy predicts local and distant control as well as survival. Eur J Cancer (1995) 1.07
Mammographic features of 455 invasive lobular carcinomas. Radiology (1992) 1.06
Estrogen receptor negative and progesterone receptor positive primary breast cancer: pathological characteristics and clinical outcome. Institut Curie Breast Cancer Study Group. Breast Cancer Res Treat (1998) 1.05
A semiparametric approach for the two-sample comparison of survival times with long-term survivors. Biometrics (2001) 1.05
Prevention of deep vein thrombosis after major knee surgery--a randomized, double-blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placebo. Thromb Haemost (1992) 1.05
Quality-of-life, mood and executive functioning after childhood craniopharyngioma treated with surgery and proton beam therapy. Brain Inj (2012) 1.05
Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy. Eur J Surg Oncol (1998) 1.05
Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy. Cancer (1996) 1.04
A phase II study of intravenous carboplatin for the treatment of recurrent gliomas. J Neurooncol (1994) 1.04
[Hepatic resection for breast cancer metastases: results and prognosis (65 cases)]. Ann Chir (2001) 1.04
Contribution of CDKN2A/P16 ( INK4A ), P14 (ARF), CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma. Fam Cancer (2010) 1.03
Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas. Cancer (2000) 1.03
Prospective validation of a novel IV busulfan fixed dosing for paediatric patients to improve therapeutic AUC targeting without drug monitoring. Cancer Chemother Pharmacol (2007) 1.03